Vanderbilt Institute for Clinical and Translational Research (VICTR)

New online repository offers physicians quick guidance on care of rare disease patients

Vanderbilt University Medical Center has collaborated with Children’s National Hospital in Washington, D.C., to develop the Rare Disease Clinical Activity Protocol Program, or RareCAP, a growing online repository of clinical protocols designed to offer quick, practical guidance on the care of patients with rare diseases.

Reyna Gordon appointed to VICTR leadership role 

Gordon’s appointment will expand and enhance training activities offered by Edge for Scholars at Vanderbilt, primarily for early career faculty on National Institutes of Health career development awards.

Illustration of clinicians and biostatisticians working collaboratively on research

Unsung Zeros: How biostatistics advances personalized health in the era of smart data

VUMC is acrawl with statistical design, bias detection and analysis that’s recognized with $532 million in federal and nonfederal research support.

From left, Jennifer Pietenpol, PhD, Eric Farber-Eger, Lauren LeStourgeon, MPH, Luisella Spiga, PhD, and John Kuriyan, PhD.

VUMC research staff honored for excellence in the lab, clinic

Laboratory and administrative personnel at Vanderbilt University Medical Center were honored on March 29 for research excellence during the 20th annual Research Staff Awards Ceremony.

Hartmann named director of UK Center for Clinical and Translational Science

Katherine Hartmann, MD, PhD, Vice President for Research Integration for Vanderbilt University Medical Center, has been named director of the University of Kentucky (UK) Center for Clinical and Translational Science.

Wesley Self, MD, MPH

How biostatistics saves lives: the Vanderbilt experience

Biostatisticians at VUMC have played a pivotal role in the redesign of clinical trials that rigorously and rapidly determine the effectiveness of life-saving treatments for acutely ill patients.

1 2 3 8